Literature DB >> 7180580

The quantitative liver function as measured by the galactose elimination capacity. II. Prognostic value and changes during disease in patients with cirrhosis.

J Lindskov.   

Abstract

The quantitative liver function, measured by the galactose elimination capacity (GEC), was determined repeatedly in 44 patients with cirrhosis during the course of the disease. After a median observation period of 57 months (range 28-85) 17 had died from liver insufficiency. GEC was found to be of prognostic value, as classification of the patient series on the basis of the median value of two extreme prognostic groups indicated that the survival of patients with GEC greater than 1.37 mmol . min-1 at entry was significantly larger than of patients with GEC below that value (p less than 0.05). The prognostic values of serum albumin and prothrombin were of the same order of magnitude. At repeated examinations during the course of the disease, the survivors always had higher GEC values than those who died from liver insufficiency. Among those who survived and those who died there were patients with both increasing and decreasing GEC values, but no significant changes were observed within the groups. The individual changes in GEC can result from changes in the balance between liver cell necrosis and regeneration, but the possibility cannot be excluded that changes are due to methodological problems in the determination of the quantitative liver function as measured by GEC.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7180580

Source DB:  PubMed          Journal:  Acta Med Scand        ISSN: 0001-6101


  4 in total

1.  The galactose elimination capacity and mortality in 781 Danish patients with newly-diagnosed liver cirrhosis: a cohort study.

Authors:  Peter Jepsen; Hendrik Vilstrup; Peter Ott; Susanne Keiding; Per K Andersen; Niels Tygstrup
Journal:  BMC Gastroenterol       Date:  2009-06-30       Impact factor: 3.067

2.  Prognostic value of galactose elimination capacity, aminopyrine breath test, and ICG clearance in patients with cirrhosis. Comparison with the Pugh score.

Authors:  C Merkel; A Gatta; M Zoli; M Bolognesi; P Angeli; T Iervese; G Marchesini; A Ruol
Journal:  Dig Dis Sci       Date:  1991-09       Impact factor: 3.199

3.  [14C]Aminopyrine breath analysis and conventional biochemical tests as predictors of survival in cirrhosis.

Authors:  D A Henry; G Kitchingman; M J Langman
Journal:  Dig Dis Sci       Date:  1985-09       Impact factor: 3.199

4.  Long-term effect of nadolol on quantitative liver function tests in patients with cirrhosis.

Authors:  C Merkel; A Gatta; D Sacerdoti; M Bolognesi; M Rondana; L Caregaro; G F Finucci; A Ruol
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.